Home › Bladder Cancer › Michigan › Canton
Bladder Cancer clinical trials in Canton, MI
4 studies for Bladder Cancer are looking for participants at sites in and around Canton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
RecruitingPhase 2
- Trinity Health Medical Center - Canton, Canton
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health Medical Center - Canton, Canton
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health Medical Center - Canton, Canton
The Vanguard Study: Testing a New Way to Screen for Cancer
RecruitingHealthy volunteers welcome
- Henry Ford Medical Center - Plymouth, Plymouth · 4 mi away
About Bladder Cancer
Bladder cancer symptoms range from lower back pain to blood in your urine. Read about important risk factors and find a list of treatments available
More about Bladder Cancer on MedlinePlus
Bladder Cancer trials in other cities
- New York City, NY34 studies
- Nashville, TN31 studies
- Houston, TX31 studies
- Boston, MA27 studies
- Dallas, TX27 studies
- Washington, DC26 studies
- Baltimore, MD24 studies
- Los Angeles, CA24 studies
- Edison, NJ22 studies
- St. Louis, MO22 studies
- Seattle, WA21 studies
- Philadelphia, PA21 studies
Other studies in Canton
- Lung Cancer9 studies
- Non-Small Cell Lung Cancer8 studies
- Prostate Cancer8 studies
- Acute Myeloid Leukemia7 studies
- Colorectal Cancer6 studies
- Kidney Cancer (Renal Cell Carcinoma)5 studies
- Breast Cancer4 studies
- Ovarian Cancer4 studies
- Chronic Lymphocytic Leukemia3 studies
- Esophageal Cancer3 studies
- Stomach Cancer3 studies
- Head and Neck Squamous Cell Carcinoma3 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.